Haemovigilance of reactions associated with red blood cell transfusion: Comparison across 17 Countries

Vox Sanguinis

Volumn 110, Issue 3, 2016, Pages 266-277

  Rogers, M A M ^a,b   Rohde, J M ^a   Blumberg, N ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Adverse reaction; Haemovigilance; International; Transfusion

Indexed keywords

ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; AUSTRALIA; BLOOD SAFETY; BLOOD TRANSFUSION REACTION; CANADA; COMPARATIVE STUDY; DEVELOPED COUNTRY; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEVER; FINLAND; FRANCE; GERMANY; HEMOSIDEROSIS; HUMAN; HYPOTENSION; INFECTION; IRELAND; JAPAN; NETHERLANDS; NEW ZEALAND; NONHUMAN; NORWAY; PAIN; PORTUGAL; PRIORITY JOURNAL; PURPURA; RISK ASSESSMENT; SEPSIS; SPAIN; SWEDEN; SWITZERLAND; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED KINGDOM; UNITED STATES; ADVERSE EFFECTS; ASIA; AUSTRALIA AND NEW ZEALAND; COMMUNICABLE DISEASE; EUROPE; RISK; STATISTICS AND NUMERICAL DATA; TRANSFUSION REACTION; TRANSMISSION; VIRUS INFECTION; WESTERN HEMISPHERE;

AMERICAS; ASIA; AUSTRALASIA; BLOOD SAFETY; COMMUNICABLE DISEASES; ERYTHROCYTE TRANSFUSION; EUROPE; HUMANS; RISK; TRANSFUSION REACTION; VIRUS DISEASES;

EID: 84952700513     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12367     Document Type: Article

References (58)

1. Salmi LR, Hervé P: L'organisation de l'hémovigilance en France. TCB 1994; 3:252-256
2. Tadokoro K: The new Japanese blood law: its impact on blood safety and usage. Dev Biol (Basel) 2007; 127:161-168
3. Folléa G, Aranko K: European Blood Alliance: The revision of the European blood directives: a major challenge for transfusion medicine. Transfus Clin Biol 2015; S1246-7820:00032-00034
4. Bolton-Maggs P, Working Expert Group & Writing Group, Royal College of Pathologists: Annual SHOT Report: Serious Hazards of Transfusion (SHOT) 2013. Available at: http://www.shotuk.org/wp-content/uploads/74280-SHOT-2014-Annual-Report-V12-WEB.pdf (accessed July 9th, 2015)
5. TRIP Hemovigilance and biovigilance office: TRIP annual report: Hemovigilance extended version, 2012. Available at: http://www.tripnet.nl/pages/en/documents/TRIP2012Hemovigilantie_ENGELS4.pdf (accessed July 9th, 2015)
6. Harvey AR, Basavaraju SV, Chung KW, et al.: Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Transfusion 2015; 55:709-718
7. National Blood Authority: Australian Haemovigilance Report: data for 2009-10 and 2010-11. Available at: http://www.blood.gov.au/haemovigilance-reporting (accessed July 9th, 2015)
8. Public Health Agency of Canada: Transfusion transmitted injuries surveillance system (TTISS): summary results for 2006-2012. Available at: http://www.phac-aspc.gc.ca/hcai-iamss/ttiss-ssit/index-eng.php (accessed July 9th, 2015)
9. Taaning EM, Sorensen B, Riisom K: Danish Registration of Transfusion Risk (DART) hemovigilance report for 2009. Available at: http://dski.dk/files/DART_2009.pdf (accessed July 9th, 2015)
10. Finnish Red Cross Blood Service: Adverse transfusion events in Finland 2007. Available at: http://www.hemovigilans.se/downloads/BSO_2007.pdf (accessed July 9th, 2015)
11. French Agency for the Safety of Health Products: Annual Haemovigilance report 2009. Available at: http://ansm.sante.fr/var/ansm_site/storage/original/application/bb2a6b52bdb935954bd985d638e0e734.pdf (accessed July 9th, 2015)
12. Lohmann A, Halbauer J, Witzenhausen C, et al.: Haeomovigilance report of the Paul-Ehrlich Institute: Assessment of the reports of serious adverse transfusion reactions, 2010. Available at: http://www.pei.de/SharedDocs/Downloads/vigilanz/haemovigilanz/publikationen/haemovigilance-report-2010.pdf?__blob=publicationFile&v=3(accessed July 9th, 2015)
13. National Haemovigilance Office: NHO Report 2010/2011, Ireland. Available at: http://www.giveblood.ie/Clinical_Services/Haemovigilance/Publications/NHO-Annual-Report-2011.pdf(accessed July 9th, 2015)
14. Japanese Red Cross Society: Non-hemolytic adverse transfusion reactions reported to JRC Blood Centers, 2012. Available at: http://www.jrc.or.jp/mr/english/(accessed July 9th, 2015)
15. Japanese Red Cross Society: Transfusion-related acute lung injury, 2012. Available at: http://www.jrc.or.jp/mr/english/(accessed July 9th, 2015)
16. Japanese Red Cross Society: Infectious cases of probably related to transfused blood components, 2012. Available at: http://www.jrc.or.jp/mr/english/(accessed July 9th, 2015)
17. Badami K, Buhrkuhl D, Sadani D, et al.: National Haemovigilance Group. National haemovigilance programme, Annual report, 2013. Available at: http://www.nzblood.co.nz/assets/Haemovigilance/Haemovigilance-Annual-Report-2013.pdf(accessed July 9th, 2015)
18. Norwegian Knowledge Centre for the Health Services: Monitoring of Blood: haemovigilance report, 2010. Available at: http://www.kunnskapssenteret.no/en/publications/surveillance-of-blood-in-norway-2010.troll.adverse-outcomes-of-transfusion(accessed July 9th, 2015)
19. De Sousa G, Miranda I, Pires I, et al.: Report of the Portuguese Haemovigilance System, 2012. Available at: http://www.hemovigilancia.net/docs/relatorio_sphv_2012.pdf(accessed July 9th, 2015)
20. De Sousa G, Miranda I, Pires I, et al.: Activity report of the services of blood and transfusion medicine, 2012. Available at: http://www.hemovigilancia.net/docs/relatorio_atividade_ss_smt_2012.pdf (accessed July 9th, 2015)
21. Hemovigilance Unit, Public Health, Quality and Innovation: Hemovigilance, Spain, 2013. Available at: http://www.msssi.gob.es/profesionales/saludPublica/medicinaTransfusional/hemovigilancia/docs/Informe2013.pdf(accessed July 9th, 2015)
22. Säfwenberg J, Palfi M: Report from the BIS - Blood Monitoring in Sweden. Hemovigilance in Sweden 2011-2013. Available at: http://www.kitm.se/sv/wp-content/uploads/2014/10/Hemovigilans-i-Sverige-2011-2013.pdf(accessed July 9th, 2015)
23. Jutzi M, Amsler L. Swissmedic Haemovigilance Annual report, Switzerland, 2013. Available at: https://www.swissmedic.ch/marktueberwachung/00138/00188/index.html?lang=en&download=NHzLpZeg7t, lnp6I0NTU042l2Z6ln1ad1IZn4Z2qZpnO2Yuq2Z6gpJCDdoN5e2ym162epYbg2c_JjKbNoKSn6A-(accessed July 9th, 2015)
24. Schreiber G, Busch MP, Kleinman SH, et al.: The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334:1685-1690
25. Trikalinos TA, Trow P, Schmid CH: Simulation-Based Comparison of Methods for Meta-Analysis of Proportions and Rates. AHRQ Publication No. 13(14)-EHC084-EF. November 2013. Available at: http://www.ncbi.nlm.nih.gov/books/NBK179162/(accessed July 9th, 2015)
26. Popovsky MA, Audet AM, Andrzejewski C Jr: Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology 1996; 12:87-89
27. Bierbaum BE, Callaghan JJ, Galante JO, et al.: An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81:2-10
28. Rana R, Fernández-Pérez ER, Khan SA, et al.: Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46:1478-1483
29. Li G, Rachmale S, Kojicic M, et al.: Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011; 51:338-343
30. Andrzejewski C Jr, Popovsky MA, Stec TC, et al.: Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects? Transfusion 2012; 52:2310-2320
31. Clifford L, Jia Q, Yadav H, et al.: Characterizing the epidemiology of perioperative transfusion-associated circulatory overload. Anesthesiology 2015; 122:21-28
32. Menis M, Anderson SA, Forshee RA, et al.: Transfusion-associated circulatory overload (TACO) and potential risk factors among the inpatient US elderly as recorded in Medicare administrative databases during 2011. Vox Sang 2014; 106:144-152
33. Paglino JC, Pomper GJ, Fisch GS, et al.: Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004; 44:16-24
34. Sanders RP, Maddirala SD, Geiger TL, et al.: Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 2005; 130:781-787
35. Kennedy LD, Case LD, Hurd DD, et al.: A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions. Transfusion 2008; 48:2285-2291
36. Menitove JE, McElligott MC, Aster RH: Febrile transfusion reaction: what blood component should be given next? Vox Sang 1982; 42:318-321
37. Dzieczkowski JS, Barrett BB, Nester D, et al.: Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Transfusion 1995; 35:20-25
38. Federowicz I, Barrett BB, Andersen JW, et al.: Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 1996; 36:21-28
39. Uhlmann EJ, Isgriggs E, Wallhermfechtel M, et al.: Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 2001; 41:997-1000
40. Domen RE, Hoeltge GA: Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 2003; 127:316-320
41. King KE, Shirey RS, Thoman SK, et al.: Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004; 44:25-29
42. Ezidiegwu CN, Lauenstein KJ, Rosales LG, et al.: Febrile nonhemolytic transfusion reactions. Management by premedication and cost implications in adult patients. Arch Pathol Lab Med 2004; 128:991-995
43. Oakley FD, Woods M, Arnold S, et al.: Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products. Transfusion 2015; 55:563-570
44. Menis M, Forshee RA, Anderson SA, et al.: Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012. Vox Sang 2015; 108:251-261
45. Badami KG, Joliffe E, Stephens M: Transfusion-associated dyspnoea - shadow or substance? Vox Sang 2015; 109:197-200.
46. Whitaker BI, Hinkins S: The 2011 National Blood Collection and Utilization Survey Report. US Department of Health and Human Services, 2011.
47. Blumberg N, Heal JM, Gettings KF, et al.: An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010; 50:2738-2744
48. Centers for Disease Control and Prevention: National Healthcare Safety Network, Biovigilance Component, Hemovigilance Module, Surveillance Protocol, v2.1.3, 2014. Available at: http://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf (accessed July 9th, 2015)
49. Stramer SL: Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Sci Ser 2014; 9:30-36
50. Blood Products Advisory Committee, Food and Drug Administration: Strategies for implementation of antibody and nucleic acid-based testing for Babesia microti in blood donors, 2015: Available at: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/bloodproductsadvisorycommittee/ucm446274.pdf (accessed July 9th, 2015)
51. Barrett BB, Anderson JW, Anderson KC: Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993; 133:228-233
52. Damgaard C, Magnussen K, Enevold C, et al.: Viable bacteria associated with red blood cells and plasma in freshly drawn blood donations. PLoS ONE 2015; 10:e0120826
53. Levy R, Pantanowitz L, Cloutier D, et al.: Development of electronic medical record charting for hospital-based transfusion and apheresis medicine services: Early adoption perspectives. J Pathol Inform 2010; 1. pii:8
54. Clifford L, Singh A, Wilson GA, et al.: Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion 2013; 53:1205-1216
55. Edgren G, Rostgaard K, Vasan SK, et al.: The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility. Transfusion 2015; 55:1600-1606
56. International Haemovigilance Network. ISTARE. Available at: http://www.ihn-org.com/haemovigilance-databases/istare-2/ (accessed September 29th, 2015)
57. The Global Vigilance and Surveillance Database for Medical Products of Human Origin. NOTIFY Library. Available at: http://www.notifylibrary.org/(accessed September 29th, 2015)
58. World Health Organization. Global Database on Blood Safety. Available at: http://www.who.int/bloodsafety/global_database/en/ (accessed September 29th, 2015)